Expanding the Scope of Bacterial CRISPR Activation with PAM- Flexible dCas9 Variants

被引:9
|
作者
Kiattisewee, Cholpisit [1 ,2 ]
Karanjia, Ava, V [1 ,2 ,3 ]
Legut, Mateusz [4 ,5 ]
Daniloski, Zharko [4 ,5 ,6 ]
Koplik, Samantha E. [7 ]
Nelson, Joely [1 ,2 ]
Kleinstiver, Benjamin P. [8 ,9 ,10 ]
Sanjana, Neville E. [4 ,5 ]
Carothers, James M. [1 ,2 ,3 ,7 ]
Zalatan, Jesse G. [1 ,2 ,3 ,11 ]
机构
[1] Univ Washington, Mol Engn & Sci Inst, Seattle, WA 98195 USA
[2] Univ Washington, Ctr Synthet Biol, Seattle, WA 98195 USA
[3] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA
[4] New York Genome Ctr, New York, NY 10013 USA
[5] NYU, Dept Biol, New York, NY 10013 USA
[6] Beam Therapeut, Cambridge, MA 02142 USA
[7] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA
[8] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA
[9] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[10] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA
[11] Univ Washington, Dept Chem, Seattle, WA 98195 USA
来源
ACS SYNTHETIC BIOLOGY | 2022年 / 11卷 / 12期
基金
美国国家科学基金会;
关键词
transcriptional regulation; engineered Cas9; PAM; CRISPRa; CRISPRi; CAS9; VARIANTS; SCREENS; NUCLEASES; KNOCKOUT; BIOLOGY;
D O I
10.1021/acssynbio.2c00405
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
CRISPR-Cas transcriptional tools have been widely applied for programmable regulation of complex biological networks. In comparison to eukaryotic systems, bacterial CRISPR activation (CRISPRa) has stringent target site requirements for effective gene activation. While genes may not always have an NGG protospacer adjacent motif (PAM) at the appropriate position, PAM-flexible dCas9 variants can expand the range of targetable sites. Here we systematically evaluate a panel of PAM flexible dCas9 variants for their ability to activate bacterial genes. We observe that dxCas9-NG provides a high dynamic range of gene activation for sites with NGN PAMs while dSpRY permits modest activity across almost any PAM. Similar trends were observed for heterologous and endogenous promoters. For all variants tested, improved PAM-flexibility comes with the trade-off that CRISPRi-mediated gene repression becomes less effective. Weaker CRISPR interference (CRISPRi) gene repression can be partially rescued by expressing multiple sgRNAs to target many sites in the gene of interest. Our work provides a framework to choose the most effective dCas9 variant for a given set of gene targets, which will further expand the utility of CRISPRa/i gene regulation in bacterial systems.
引用
收藏
页码:4103 / 4112
页数:10
相关论文
共 50 条
  • [1] Crispr/dCas9 and gene activation
    Akinci, Ersin
    Unal, Pelin
    Badakul, Gamze
    Yildiz, Mehmet
    JOURNAL OF BIOTECHNOLOGY, 2017, 256 : S42 - S42
  • [2] Activation of pluripotency genes using CRISPR/dCas9 system
    Vilarino, M.
    Meckler, J.
    Segal, D. J.
    Ross, J. P.
    TRANSGENIC RESEARCH, 2016, 25 (01) : 116 - 116
  • [3] Transcriptional regulation by CRISPR/dCas9 in common wheat
    Zhou, Huajie
    Xu, Lei
    Li, Feng
    Li, Yansha
    GENE, 2022, 807
  • [4] Application of Various Delivery Methods for CRISPR/dCas9
    Liu, Zhixi
    Liao, Zhi
    Chen, Yan
    Han, Lizhu
    Yin, Qinan
    Xiao, Hongtao
    MOLECULAR BIOTECHNOLOGY, 2020, 62 (08) : 355 - 363
  • [5] Epigenetic editing by CRISPR/dCas9 in Plasmodium falciparum
    Xiao, Bo
    Yin, Shigang
    Hu, Yang
    Sun, Maoxin
    Wei, Jieqiong
    Huang, Zhenghui
    Wen, Yuhao
    Dai, Xueyu
    Chen, Huiling
    Mu, Jianbing
    Cui, Liwang
    Jiang, Lubin
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (01) : 255 - 260
  • [6] Application of Various Delivery Methods for CRISPR/dCas9
    Zhixi Liu
    Zhi Liao
    Yan Chen
    Lizhu Han
    Qinan Yin
    Hongtao Xiao
    Molecular Biotechnology, 2020, 62 : 355 - 363
  • [7] Programmable activation of Bombyx gene expression using CRISPR/dCas9 fusion systems
    Wang, Xiao-Gang
    Ma, San-Yuan
    Chang, Jia-Song
    Shi, Run
    Wang, Ruo-Lin
    Zhao, Ping
    Xia, Qing-You
    INSECT SCIENCE, 2019, 26 (06) : 983 - 990
  • [8] CRISPR/dCas9 for hepatic fibrosis therapy: implications and challenges
    Luo, Nianan
    Zhong, Wenjun
    Li, Jiangbin
    Lu, Jianguo
    Dong, Rui
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (12) : 11403 - 11408
  • [9] CRISPR/dCas9 for hepatic fibrosis therapy: implications and challenges
    Nianan Luo
    Wenjun Zhong
    Jiangbin Li
    Jianguo Lu
    Rui Dong
    Molecular Biology Reports, 2022, 49 : 11403 - 11408
  • [10] CRISPR/dCas9 technologies for transcriptome manipulation and disease research
    Qi, S.
    PHYTOPATHOLOGY, 2016, 106 (12) : 176 - 176